logo

For the Inventor, By the Inventor

San Mateo, CA, United States of America

Hsin Wang

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Cytomx Therapeutics, Inc.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hsin Wang. Retrieved from https://idiyas.com/inventor/hsin-wang-zipd3opv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 9.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal3 out of 94 
 
Cytomx Therapeutics, Inc.
 patents

Years Active: 2022-2024

Loading Chart...
3 patents (USPTO):Explore Patents
1. 12091442 - Activatable cytokine constructs and related compositions and methods (2024-09-17),
2. 11667687 - Masked activatable interferon constructs (2023-06-06),
3. 11365233 - Activatable cytokine constructs and related compositions and methods (2022-06-21),

Title: Top Inventor in San Mateo

Introduction: Thierry Cruanes is a prominent inventor based in San Mateo, California. Notably, she is a woman who has made significant contributions to her field.

Latest Patents: Thierry has recently been awarded several patents that showcase her innovative ideas and technical expertise.

Career Highlights: Throughout her career, Thierry has achieved numerous milestones that highlight her dedication and impact in the industry.

Collaborations: She has worked with various organizations and individuals, fostering partnerships that enhance her work and broaden her influence.

Conclusion: Thierry Cruanes stands out as a leading inventor, inspiring others with her achievements and commitment to innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…